nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—osteoarthritis—Prednisone—hematologic cancer	0.264	1	CpDpCtD
Tolmetin—MPO—hematologic cancer	0.224	1	CbGaD
Tolmetin—PTGS2—Lenalidomide—hematologic cancer	0.0501	0.18	CbGbCtD
Tolmetin—MPO—Cisplatin—hematologic cancer	0.0332	0.119	CbGbCtD
Tolmetin—PTGS2—Thalidomide—hematologic cancer	0.0268	0.0959	CbGbCtD
Tolmetin—PTGS1—Bortezomib—hematologic cancer	0.0259	0.093	CbGbCtD
Tolmetin—PTGS1—Thalidomide—hematologic cancer	0.0226	0.081	CbGbCtD
Tolmetin—PTGS1—Ifosfamide—hematologic cancer	0.0199	0.0713	CbGbCtD
Tolmetin—PTGS1—Imatinib—hematologic cancer	0.019	0.0681	CbGbCtD
Tolmetin—PTGS2—Triamcinolone—hematologic cancer	0.0186	0.0665	CbGbCtD
Tolmetin—PTGS2—Betamethasone—hematologic cancer	0.0159	0.0571	CbGbCtD
Tolmetin—PTGS2—Cisplatin—hematologic cancer	0.0115	0.0411	CbGbCtD
Tolmetin—PTGS2—Etoposide—hematologic cancer	0.0113	0.0404	CbGbCtD
Tolmetin—PTGS1—Etoposide—hematologic cancer	0.00951	0.0341	CbGbCtD
Tolmetin—PTGS2—Dexamethasone—hematologic cancer	0.00926	0.0332	CbGbCtD
Tolmetin—SLC22A6—Methotrexate—hematologic cancer	0.00551	0.0197	CbGbCtD
Tolmetin—PTGS2—ovarian follicle—hematologic cancer	0.00449	0.203	CbGeAlD
Tolmetin—TDO2—lung—hematologic cancer	0.00216	0.0977	CbGeAlD
Tolmetin—TDO2—lymph node—hematologic cancer	0.00148	0.0668	CbGeAlD
Tolmetin—CXCL8—blood—hematologic cancer	0.00135	0.0614	CbGeAlD
Tolmetin—CXCL8—bone marrow—hematologic cancer	0.00131	0.0594	CbGeAlD
Tolmetin—MPO—hematopoietic system—hematologic cancer	0.0012	0.0542	CbGeAlD
Tolmetin—CXCL8—lung—hematologic cancer	0.00119	0.0538	CbGeAlD
Tolmetin—CXCL8—testis—hematologic cancer	0.00112	0.0508	CbGeAlD
Tolmetin—CXCL8—lymph node—hematologic cancer	0.000812	0.0368	CbGeAlD
Tolmetin—MPO—blood—hematologic cancer	0.000792	0.0359	CbGeAlD
Tolmetin—MPO—bone marrow—hematologic cancer	0.000767	0.0347	CbGeAlD
Tolmetin—MPO—lung—hematologic cancer	0.000694	0.0315	CbGeAlD
Tolmetin—MPO—testis—hematologic cancer	0.000655	0.0297	CbGeAlD
Tolmetin—PTGS1—hematopoietic system—hematologic cancer	0.000567	0.0257	CbGeAlD
Tolmetin—PTGS2—hematopoietic system—hematologic cancer	0.000542	0.0246	CbGeAlD
Tolmetin—MPO—lymph node—hematologic cancer	0.000475	0.0215	CbGeAlD
Tolmetin—Suprofen—UGT1A1—hematologic cancer	0.000438	0.294	CrCbGaD
Tolmetin—PTGS1—blood—hematologic cancer	0.000376	0.017	CbGeAlD
Tolmetin—PTGS2—blood—hematologic cancer	0.000359	0.0163	CbGeAlD
Tolmetin—PTGS2—bone marrow—hematologic cancer	0.000348	0.0157	CbGeAlD
Tolmetin—PTGS1—lung—hematologic cancer	0.000329	0.0149	CbGeAlD
Tolmetin—Indomethacin—ABCC3—hematologic cancer	0.000323	0.217	CrCbGaD
Tolmetin—PTGS2—lung—hematologic cancer	0.000315	0.0143	CbGeAlD
Tolmetin—PTGS1—testis—hematologic cancer	0.000311	0.0141	CbGeAlD
Tolmetin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000291	0.209	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000291	0.209	CbGdCrCtD
Tolmetin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000285	0.205	CbGdCrCtD
Tolmetin—Indomethacin—UGT1A1—hematologic cancer	0.000279	0.187	CrCbGaD
Tolmetin—Aminohippurate—SLC22A1—hematologic cancer	0.000244	0.164	CrCbGaD
Tolmetin—PTGS1—lymph node—hematologic cancer	0.000225	0.0102	CbGeAlD
Tolmetin—PTGS2—lymph node—hematologic cancer	0.000215	0.00975	CbGeAlD
Tolmetin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000176	0.126	CbGdCrCtD
Tolmetin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000176	0.126	CbGdCrCtD
Tolmetin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000172	0.124	CbGdCrCtD
Tolmetin—Aminohippurate—ABCB1—hematologic cancer	7.11e-05	0.0477	CrCbGaD
Tolmetin—Indomethacin—ALB—hematologic cancer	6.83e-05	0.0459	CrCbGaD
Tolmetin—Indomethacin—ABCB1—hematologic cancer	6.52e-05	0.0438	CrCbGaD
Tolmetin—Gastritis—Epirubicin—hematologic cancer	5.29e-05	0.000444	CcSEcCtD
Tolmetin—Urticaria—Ifosfamide—hematologic cancer	5.27e-05	0.000442	CcSEcCtD
Tolmetin—Headache—Hydroxyurea—hematologic cancer	5.25e-05	0.000441	CcSEcCtD
Tolmetin—Constipation—Gemcitabine—hematologic cancer	5.25e-05	0.00044	CcSEcCtD
Tolmetin—Abdominal pain—Ifosfamide—hematologic cancer	5.24e-05	0.00044	CcSEcCtD
Tolmetin—Body temperature increased—Ifosfamide—hematologic cancer	5.24e-05	0.00044	CcSEcCtD
Tolmetin—Anaphylactic shock—Etoposide—hematologic cancer	5.24e-05	0.00044	CcSEcCtD
Tolmetin—Asthenia—Thiotepa—hematologic cancer	5.23e-05	0.000439	CcSEcCtD
Tolmetin—Diarrhoea—Vinorelbine—hematologic cancer	5.23e-05	0.000438	CcSEcCtD
Tolmetin—Nausea—Melphalan—hematologic cancer	5.19e-05	0.000436	CcSEcCtD
Tolmetin—Dizziness—Bortezomib—hematologic cancer	5.17e-05	0.000434	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisolone—hematologic cancer	5.17e-05	0.000434	CcSEcCtD
Tolmetin—Oedema—Prednisolone—hematologic cancer	5.17e-05	0.000434	CcSEcCtD
Tolmetin—Dysuria—Methotrexate—hematologic cancer	5.16e-05	0.000433	CcSEcCtD
Tolmetin—Gastrointestinal pain—Irinotecan—hematologic cancer	5.15e-05	0.000432	CcSEcCtD
Tolmetin—Gastrointestinal pain—Mitoxantrone—hematologic cancer	5.15e-05	0.000432	CcSEcCtD
Tolmetin—Thrombocytopenia—Etoposide—hematologic cancer	5.13e-05	0.00043	CcSEcCtD
Tolmetin—Abdominal pain—Vincristine—hematologic cancer	5.11e-05	0.000429	CcSEcCtD
Tolmetin—Body temperature increased—Vincristine—hematologic cancer	5.11e-05	0.000429	CcSEcCtD
Tolmetin—Asthenia—Thalidomide—hematologic cancer	5.06e-05	0.000425	CcSEcCtD
Tolmetin—Dizziness—Vinorelbine—hematologic cancer	5.05e-05	0.000424	CcSEcCtD
Tolmetin—Nausea—Lenalidomide—hematologic cancer	5.05e-05	0.000424	CcSEcCtD
Tolmetin—Urticaria—Mitoxantrone—hematologic cancer	5e-05	0.00042	CcSEcCtD
Tolmetin—Diarrhoea—Thiotepa—hematologic cancer	4.99e-05	0.000419	CcSEcCtD
Tolmetin—Body temperature increased—Mitoxantrone—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Body temperature increased—Irinotecan—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Abdominal pain—Mitoxantrone—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Abdominal pain—Irinotecan—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Nausea—Hydroxyurea—hematologic cancer	4.98e-05	0.000418	CcSEcCtD
Tolmetin—Vomiting—Bortezomib—hematologic cancer	4.97e-05	0.000417	CcSEcCtD
Tolmetin—Vomiting—Bleomycin—hematologic cancer	4.93e-05	0.000414	CcSEcCtD
Tolmetin—Drowsiness—Methotrexate—hematologic cancer	4.92e-05	0.000413	CcSEcCtD
Tolmetin—Headache—Bortezomib—hematologic cancer	4.9e-05	0.000411	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—hematologic cancer	4.89e-05	0.000411	CcSEcCtD
Tolmetin—Asthenia—Carmustine—hematologic cancer	4.86e-05	0.000408	CcSEcCtD
Tolmetin—Vomiting—Vinorelbine—hematologic cancer	4.86e-05	0.000407	CcSEcCtD
Tolmetin—Body temperature increased—Gemcitabine—hematologic cancer	4.85e-05	0.000407	CcSEcCtD
Tolmetin—Renal failure—Methotrexate—hematologic cancer	4.84e-05	0.000406	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—hematologic cancer	4.83e-05	0.000405	CcSEcCtD
Tolmetin—Diarrhoea—Thalidomide—hematologic cancer	4.83e-05	0.000405	CcSEcCtD
Tolmetin—Dizziness—Thiotepa—hematologic cancer	4.82e-05	0.000405	CcSEcCtD
Tolmetin—Asthenia—Alitretinoin—hematologic cancer	4.82e-05	0.000404	CcSEcCtD
Tolmetin—Stomatitis—Methotrexate—hematologic cancer	4.8e-05	0.000402	CcSEcCtD
Tolmetin—Headache—Vinorelbine—hematologic cancer	4.78e-05	0.000401	CcSEcCtD
Tolmetin—Asthenia—Ifosfamide—hematologic cancer	4.76e-05	0.000399	CcSEcCtD
Tolmetin—Oedema—Triamcinolone—hematologic cancer	4.75e-05	0.000399	CcSEcCtD
Tolmetin—Anaphylactic shock—Triamcinolone—hematologic cancer	4.75e-05	0.000399	CcSEcCtD
Tolmetin—Weight increased—Epirubicin—hematologic cancer	4.7e-05	0.000394	CcSEcCtD
Tolmetin—Haematuria—Methotrexate—hematologic cancer	4.69e-05	0.000394	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—hematologic cancer	4.67e-05	0.000392	CcSEcCtD
Tolmetin—Dizziness—Thalidomide—hematologic cancer	4.66e-05	0.000391	CcSEcCtD
Tolmetin—Somnolence—Etoposide—hematologic cancer	4.66e-05	0.000391	CcSEcCtD
Tolmetin—Nausea—Bortezomib—hematologic cancer	4.65e-05	0.00039	CcSEcCtD
Tolmetin—Epistaxis—Methotrexate—hematologic cancer	4.64e-05	0.000389	CcSEcCtD
Tolmetin—Asthenia—Vincristine—hematologic cancer	4.64e-05	0.000389	CcSEcCtD
Tolmetin—Vomiting—Thiotepa—hematologic cancer	4.64e-05	0.000389	CcSEcCtD
Tolmetin—Diarrhoea—Carmustine—hematologic cancer	4.64e-05	0.000389	CcSEcCtD
Tolmetin—Nausea—Bleomycin—hematologic cancer	4.61e-05	0.000387	CcSEcCtD
Tolmetin—Drowsiness—Epirubicin—hematologic cancer	4.6e-05	0.000386	CcSEcCtD
Tolmetin—Diarrhoea—Alitretinoin—hematologic cancer	4.59e-05	0.000385	CcSEcCtD
Tolmetin—Agranulocytosis—Methotrexate—hematologic cancer	4.59e-05	0.000385	CcSEcCtD
Tolmetin—Headache—Thiotepa—hematologic cancer	4.57e-05	0.000383	CcSEcCtD
Tolmetin—Diarrhoea—Ifosfamide—hematologic cancer	4.54e-05	0.000381	CcSEcCtD
Tolmetin—Nausea—Vinorelbine—hematologic cancer	4.54e-05	0.000381	CcSEcCtD
Tolmetin—Renal failure—Epirubicin—hematologic cancer	4.53e-05	0.00038	CcSEcCtD
Tolmetin—Body temperature increased—Cisplatin—hematologic cancer	4.52e-05	0.000379	CcSEcCtD
Tolmetin—Asthenia—Mitoxantrone—hematologic cancer	4.52e-05	0.000379	CcSEcCtD
Tolmetin—Asthenia—Irinotecan—hematologic cancer	4.52e-05	0.000379	CcSEcCtD
Tolmetin—Stomatitis—Epirubicin—hematologic cancer	4.49e-05	0.000377	CcSEcCtD
Tolmetin—Vomiting—Thalidomide—hematologic cancer	4.49e-05	0.000376	CcSEcCtD
Tolmetin—Dizziness—Carmustine—hematologic cancer	4.48e-05	0.000376	CcSEcCtD
Tolmetin—Constipation—Etoposide—hematologic cancer	4.48e-05	0.000376	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—hematologic cancer	4.48e-05	0.000376	CcSEcCtD
Tolmetin—Dysuria—Doxorubicin—hematologic cancer	4.47e-05	0.000375	CcSEcCtD
Tolmetin—Dizziness—Alitretinoin—hematologic cancer	4.44e-05	0.000372	CcSEcCtD
Tolmetin—Diarrhoea—Vincristine—hematologic cancer	4.43e-05	0.000371	CcSEcCtD
Tolmetin—Headache—Thalidomide—hematologic cancer	4.42e-05	0.000371	CcSEcCtD
Tolmetin—Hepatitis—Methotrexate—hematologic cancer	4.42e-05	0.000371	CcSEcCtD
Tolmetin—Asthenia—Gemcitabine—hematologic cancer	4.4e-05	0.000369	CcSEcCtD
Tolmetin—Haematuria—Epirubicin—hematologic cancer	4.39e-05	0.000368	CcSEcCtD
Tolmetin—Dizziness—Ifosfamide—hematologic cancer	4.39e-05	0.000368	CcSEcCtD
Tolmetin—Weight increased—Doxorubicin—hematologic cancer	4.35e-05	0.000365	CcSEcCtD
Tolmetin—Epistaxis—Epirubicin—hematologic cancer	4.34e-05	0.000364	CcSEcCtD
Tolmetin—Nausea—Thiotepa—hematologic cancer	4.33e-05	0.000364	CcSEcCtD
Tolmetin—Weight decreased—Doxorubicin—hematologic cancer	4.32e-05	0.000363	CcSEcCtD
Tolmetin—Anaphylactic shock—Betamethasone—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Oedema—Dexamethasone—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Anaphylactic shock—Dexamethasone—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Oedema—Betamethasone—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Diarrhoea—Mitoxantrone—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Diarrhoea—Irinotecan—hematologic cancer	4.31e-05	0.000362	CcSEcCtD
Tolmetin—Vomiting—Carmustine—hematologic cancer	4.31e-05	0.000361	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—hematologic cancer	4.3e-05	0.000361	CcSEcCtD
Tolmetin—Gastrointestinal pain—Etoposide—hematologic cancer	4.28e-05	0.000359	CcSEcCtD
Tolmetin—Dizziness—Vincristine—hematologic cancer	4.28e-05	0.000359	CcSEcCtD
Tolmetin—Vomiting—Alitretinoin—hematologic cancer	4.27e-05	0.000358	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—hematologic cancer	4.26e-05	0.000357	CcSEcCtD
Tolmetin—Visual impairment—Methotrexate—hematologic cancer	4.26e-05	0.000357	CcSEcCtD
Tolmetin—Headache—Carmustine—hematologic cancer	4.24e-05	0.000356	CcSEcCtD
Tolmetin—Thrombocytopenia—Dexamethasone—hematologic cancer	4.22e-05	0.000354	CcSEcCtD
Tolmetin—Thrombocytopenia—Betamethasone—hematologic cancer	4.22e-05	0.000354	CcSEcCtD
Tolmetin—Vomiting—Ifosfamide—hematologic cancer	4.22e-05	0.000354	CcSEcCtD
Tolmetin—Headache—Alitretinoin—hematologic cancer	4.2e-05	0.000353	CcSEcCtD
Tolmetin—Diarrhoea—Gemcitabine—hematologic cancer	4.2e-05	0.000352	CcSEcCtD
Tolmetin—Nausea—Thalidomide—hematologic cancer	4.19e-05	0.000352	CcSEcCtD
Tolmetin—Renal failure—Doxorubicin—hematologic cancer	4.19e-05	0.000351	CcSEcCtD
Tolmetin—Dyspepsia—Triamcinolone—hematologic cancer	4.18e-05	0.000351	CcSEcCtD
Tolmetin—Erythema multiforme—Methotrexate—hematologic cancer	4.18e-05	0.00035	CcSEcCtD
Tolmetin—Dizziness—Irinotecan—hematologic cancer	4.17e-05	0.000349	CcSEcCtD
Tolmetin—Urticaria—Etoposide—hematologic cancer	4.16e-05	0.000349	CcSEcCtD
Tolmetin—Stomatitis—Doxorubicin—hematologic cancer	4.15e-05	0.000348	CcSEcCtD
Tolmetin—Abdominal pain—Etoposide—hematologic cancer	4.14e-05	0.000348	CcSEcCtD
Tolmetin—Body temperature increased—Etoposide—hematologic cancer	4.14e-05	0.000348	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—hematologic cancer	4.14e-05	0.000347	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—hematologic cancer	4.13e-05	0.000347	CcSEcCtD
Tolmetin—Tinnitus—Methotrexate—hematologic cancer	4.12e-05	0.000346	CcSEcCtD
Tolmetin—Vomiting—Vincristine—hematologic cancer	4.11e-05	0.000345	CcSEcCtD
Tolmetin—Urticaria—Prednisolone—hematologic cancer	4.11e-05	0.000344	CcSEcCtD
Tolmetin—Asthenia—Cisplatin—hematologic cancer	4.1e-05	0.000344	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—hematologic cancer	4.06e-05	0.000341	CcSEcCtD
Tolmetin—Headache—Vincristine—hematologic cancer	4.05e-05	0.00034	CcSEcCtD
Tolmetin—Nausea—Carmustine—hematologic cancer	4.02e-05	0.000338	CcSEcCtD
Tolmetin—Epistaxis—Doxorubicin—hematologic cancer	4.02e-05	0.000337	CcSEcCtD
Tolmetin—Vomiting—Mitoxantrone—hematologic cancer	4e-05	0.000336	CcSEcCtD
Tolmetin—Vomiting—Irinotecan—hematologic cancer	4e-05	0.000336	CcSEcCtD
Tolmetin—Nausea—Alitretinoin—hematologic cancer	3.99e-05	0.000335	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—hematologic cancer	3.98e-05	0.000334	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—hematologic cancer	3.98e-05	0.000334	CcSEcCtD
Tolmetin—Headache—Irinotecan—hematologic cancer	3.95e-05	0.000331	CcSEcCtD
Tolmetin—Headache—Mitoxantrone—hematologic cancer	3.95e-05	0.000331	CcSEcCtD
Tolmetin—Nausea—Ifosfamide—hematologic cancer	3.94e-05	0.000331	CcSEcCtD
Tolmetin—Diarrhoea—Cisplatin—hematologic cancer	3.91e-05	0.000328	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—hematologic cancer	3.91e-05	0.000328	CcSEcCtD
Tolmetin—Vomiting—Gemcitabine—hematologic cancer	3.9e-05	0.000327	CcSEcCtD
Tolmetin—Tinnitus—Epirubicin—hematologic cancer	3.85e-05	0.000323	CcSEcCtD
Tolmetin—Headache—Gemcitabine—hematologic cancer	3.84e-05	0.000323	CcSEcCtD
Tolmetin—Nausea—Vincristine—hematologic cancer	3.84e-05	0.000322	CcSEcCtD
Tolmetin—Hepatitis—Doxorubicin—hematologic cancer	3.82e-05	0.000321	CcSEcCtD
Tolmetin—Dyspepsia—Betamethasone—hematologic cancer	3.8e-05	0.000318	CcSEcCtD
Tolmetin—Dyspepsia—Dexamethasone—hematologic cancer	3.8e-05	0.000318	CcSEcCtD
Tolmetin—Urticaria—Triamcinolone—hematologic cancer	3.78e-05	0.000317	CcSEcCtD
Tolmetin—Asthenia—Etoposide—hematologic cancer	3.76e-05	0.000315	CcSEcCtD
Tolmetin—Body temperature increased—Triamcinolone—hematologic cancer	3.76e-05	0.000315	CcSEcCtD
Tolmetin—Anaphylactic shock—Prednisone—hematologic cancer	3.75e-05	0.000315	CcSEcCtD
Tolmetin—Oedema—Prednisone—hematologic cancer	3.75e-05	0.000315	CcSEcCtD
Tolmetin—Nausea—Irinotecan—hematologic cancer	3.74e-05	0.000314	CcSEcCtD
Tolmetin—Nausea—Mitoxantrone—hematologic cancer	3.74e-05	0.000314	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—hematologic cancer	3.69e-05	0.000309	CcSEcCtD
Tolmetin—Nausea—Gemcitabine—hematologic cancer	3.64e-05	0.000306	CcSEcCtD
Tolmetin—Vomiting—Cisplatin—hematologic cancer	3.64e-05	0.000305	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—hematologic cancer	3.62e-05	0.000303	CcSEcCtD
Tolmetin—Diarrhoea—Etoposide—hematologic cancer	3.58e-05	0.000301	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—hematologic cancer	3.57e-05	0.000299	CcSEcCtD
Tolmetin—Flatulence—Epirubicin—hematologic cancer	3.55e-05	0.000298	CcSEcCtD
Tolmetin—Gastrointestinal pain—Betamethasone—hematologic cancer	3.53e-05	0.000296	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.53e-05	0.000296	CcSEcCtD
Tolmetin—Dizziness—Etoposide—hematologic cancer	3.46e-05	0.000291	CcSEcCtD
Tolmetin—Urticaria—Betamethasone—hematologic cancer	3.43e-05	0.000287	CcSEcCtD
Tolmetin—Urticaria—Dexamethasone—hematologic cancer	3.43e-05	0.000287	CcSEcCtD
Tolmetin—Dizziness—Prednisolone—hematologic cancer	3.42e-05	0.000287	CcSEcCtD
Tolmetin—Asthenia—Triamcinolone—hematologic cancer	3.41e-05	0.000286	CcSEcCtD
Tolmetin—Abdominal pain—Betamethasone—hematologic cancer	3.41e-05	0.000286	CcSEcCtD
Tolmetin—Body temperature increased—Dexamethasone—hematologic cancer	3.41e-05	0.000286	CcSEcCtD
Tolmetin—Abdominal pain—Dexamethasone—hematologic cancer	3.41e-05	0.000286	CcSEcCtD
Tolmetin—Body temperature increased—Betamethasone—hematologic cancer	3.41e-05	0.000286	CcSEcCtD
Tolmetin—Nausea—Cisplatin—hematologic cancer	3.4e-05	0.000285	CcSEcCtD
Tolmetin—Vomiting—Etoposide—hematologic cancer	3.33e-05	0.00028	CcSEcCtD
Tolmetin—Dyspepsia—Prednisone—hematologic cancer	3.31e-05	0.000277	CcSEcCtD
Tolmetin—Headache—Etoposide—hematologic cancer	3.28e-05	0.000275	CcSEcCtD
Tolmetin—Flatulence—Doxorubicin—hematologic cancer	3.28e-05	0.000275	CcSEcCtD
Tolmetin—Chest pain—Methotrexate—hematologic cancer	3.27e-05	0.000275	CcSEcCtD
Tolmetin—Headache—Prednisolone—hematologic cancer	3.24e-05	0.000272	CcSEcCtD
Tolmetin—Constipation—Prednisone—hematologic cancer	3.21e-05	0.000269	CcSEcCtD
Tolmetin—Dizziness—Triamcinolone—hematologic cancer	3.14e-05	0.000264	CcSEcCtD
Tolmetin—Anaphylactic shock—Methotrexate—hematologic cancer	3.14e-05	0.000263	CcSEcCtD
Tolmetin—Nausea—Etoposide—hematologic cancer	3.11e-05	0.000261	CcSEcCtD
Tolmetin—Asthenia—Dexamethasone—hematologic cancer	3.09e-05	0.00026	CcSEcCtD
Tolmetin—Asthenia—Betamethasone—hematologic cancer	3.09e-05	0.00026	CcSEcCtD
Tolmetin—Thrombocytopenia—Methotrexate—hematologic cancer	3.07e-05	0.000258	CcSEcCtD
Tolmetin—Gastrointestinal pain—Prednisone—hematologic cancer	3.07e-05	0.000258	CcSEcCtD
Tolmetin—Nausea—Prednisolone—hematologic cancer	3.07e-05	0.000258	CcSEcCtD
Tolmetin—Chest pain—Epirubicin—hematologic cancer	3.06e-05	0.000257	CcSEcCtD
Tolmetin—Vomiting—Triamcinolone—hematologic cancer	3.02e-05	0.000254	CcSEcCtD
Tolmetin—Urticaria—Prednisone—hematologic cancer	2.98e-05	0.00025	CcSEcCtD
Tolmetin—Headache—Triamcinolone—hematologic cancer	2.98e-05	0.00025	CcSEcCtD
Tolmetin—Abdominal pain—Prednisone—hematologic cancer	2.97e-05	0.000249	CcSEcCtD
Tolmetin—Body temperature increased—Prednisone—hematologic cancer	2.97e-05	0.000249	CcSEcCtD
Tolmetin—Diarrhoea—Betamethasone—hematologic cancer	2.95e-05	0.000248	CcSEcCtD
Tolmetin—Diarrhoea—Dexamethasone—hematologic cancer	2.95e-05	0.000248	CcSEcCtD
Tolmetin—Oedema—Epirubicin—hematologic cancer	2.94e-05	0.000246	CcSEcCtD
Tolmetin—Anaphylactic shock—Epirubicin—hematologic cancer	2.94e-05	0.000246	CcSEcCtD
Tolmetin—Thrombocytopenia—Epirubicin—hematologic cancer	2.88e-05	0.000241	CcSEcCtD
Tolmetin—Dizziness—Dexamethasone—hematologic cancer	2.85e-05	0.000239	CcSEcCtD
Tolmetin—Dizziness—Betamethasone—hematologic cancer	2.85e-05	0.000239	CcSEcCtD
Tolmetin—Chest pain—Doxorubicin—hematologic cancer	2.83e-05	0.000238	CcSEcCtD
Tolmetin—Nausea—Triamcinolone—hematologic cancer	2.82e-05	0.000237	CcSEcCtD
Tolmetin—Somnolence—Methotrexate—hematologic cancer	2.79e-05	0.000234	CcSEcCtD
Tolmetin—Dyspepsia—Methotrexate—hematologic cancer	2.76e-05	0.000232	CcSEcCtD
Tolmetin—Vomiting—Dexamethasone—hematologic cancer	2.74e-05	0.00023	CcSEcCtD
Tolmetin—Vomiting—Betamethasone—hematologic cancer	2.74e-05	0.00023	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.72e-05	0.000228	CcSEcCtD
Tolmetin—Oedema—Doxorubicin—hematologic cancer	2.72e-05	0.000228	CcSEcCtD
Tolmetin—Headache—Dexamethasone—hematologic cancer	2.7e-05	0.000227	CcSEcCtD
Tolmetin—Headache—Betamethasone—hematologic cancer	2.7e-05	0.000227	CcSEcCtD
Tolmetin—Asthenia—Prednisone—hematologic cancer	2.69e-05	0.000226	CcSEcCtD
Tolmetin—Thrombocytopenia—Doxorubicin—hematologic cancer	2.66e-05	0.000223	CcSEcCtD
Tolmetin—Somnolence—Epirubicin—hematologic cancer	2.61e-05	0.000219	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—hematologic cancer	2.59e-05	0.000217	CcSEcCtD
Tolmetin—Diarrhoea—Prednisone—hematologic cancer	2.57e-05	0.000216	CcSEcCtD
Tolmetin—Gastrointestinal pain—Methotrexate—hematologic cancer	2.57e-05	0.000215	CcSEcCtD
Tolmetin—Nausea—Betamethasone—hematologic cancer	2.56e-05	0.000215	CcSEcCtD
Tolmetin—Nausea—Dexamethasone—hematologic cancer	2.56e-05	0.000215	CcSEcCtD
Tolmetin—Constipation—Epirubicin—hematologic cancer	2.51e-05	0.000211	CcSEcCtD
Tolmetin—Urticaria—Methotrexate—hematologic cancer	2.49e-05	0.000209	CcSEcCtD
Tolmetin—Dizziness—Prednisone—hematologic cancer	2.48e-05	0.000208	CcSEcCtD
Tolmetin—Body temperature increased—Methotrexate—hematologic cancer	2.48e-05	0.000208	CcSEcCtD
Tolmetin—Abdominal pain—Methotrexate—hematologic cancer	2.48e-05	0.000208	CcSEcCtD
Tolmetin—Somnolence—Doxorubicin—hematologic cancer	2.42e-05	0.000203	CcSEcCtD
Tolmetin—Gastrointestinal pain—Epirubicin—hematologic cancer	2.4e-05	0.000201	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—hematologic cancer	2.39e-05	0.000201	CcSEcCtD
Tolmetin—Vomiting—Prednisone—hematologic cancer	2.39e-05	0.0002	CcSEcCtD
Tolmetin—Headache—Prednisone—hematologic cancer	2.35e-05	0.000197	CcSEcCtD
Tolmetin—Urticaria—Epirubicin—hematologic cancer	2.33e-05	0.000196	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—hematologic cancer	2.32e-05	0.000195	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—hematologic cancer	2.32e-05	0.000195	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—hematologic cancer	2.32e-05	0.000195	CcSEcCtD
Tolmetin—Asthenia—Methotrexate—hematologic cancer	2.25e-05	0.000189	CcSEcCtD
Tolmetin—Nausea—Prednisone—hematologic cancer	2.23e-05	0.000187	CcSEcCtD
Tolmetin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.22e-05	0.000186	CcSEcCtD
Tolmetin—Urticaria—Doxorubicin—hematologic cancer	2.16e-05	0.000181	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—hematologic cancer	2.15e-05	0.00018	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—hematologic cancer	2.15e-05	0.00018	CcSEcCtD
Tolmetin—Diarrhoea—Methotrexate—hematologic cancer	2.15e-05	0.00018	CcSEcCtD
Tolmetin—Asthenia—Epirubicin—hematologic cancer	2.11e-05	0.000177	CcSEcCtD
Tolmetin—Dizziness—Methotrexate—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Tolmetin—Diarrhoea—Epirubicin—hematologic cancer	2.01e-05	0.000169	CcSEcCtD
Tolmetin—Vomiting—Methotrexate—hematologic cancer	2e-05	0.000167	CcSEcCtD
Tolmetin—Headache—Methotrexate—hematologic cancer	1.97e-05	0.000165	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—hematologic cancer	1.95e-05	0.000164	CcSEcCtD
Tolmetin—Dizziness—Epirubicin—hematologic cancer	1.94e-05	0.000163	CcSEcCtD
Tolmetin—Vomiting—Epirubicin—hematologic cancer	1.87e-05	0.000157	CcSEcCtD
Tolmetin—Nausea—Methotrexate—hematologic cancer	1.86e-05	0.000156	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—hematologic cancer	1.86e-05	0.000156	CcSEcCtD
Tolmetin—Headache—Epirubicin—hematologic cancer	1.84e-05	0.000154	CcSEcCtD
Tolmetin—Dizziness—Doxorubicin—hematologic cancer	1.8e-05	0.000151	CcSEcCtD
Tolmetin—Nausea—Epirubicin—hematologic cancer	1.74e-05	0.000146	CcSEcCtD
Tolmetin—Vomiting—Doxorubicin—hematologic cancer	1.73e-05	0.000145	CcSEcCtD
Tolmetin—Headache—Doxorubicin—hematologic cancer	1.7e-05	0.000143	CcSEcCtD
Tolmetin—Nausea—Doxorubicin—hematologic cancer	1.61e-05	0.000135	CcSEcCtD
Tolmetin—PTGS1—Metabolism—ADCY7—hematologic cancer	6.44e-06	7.28e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NCOA3—hematologic cancer	6.44e-06	7.28e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGF19—hematologic cancer	6.44e-06	7.28e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—JAK2—hematologic cancer	6.42e-06	7.26e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAP2K1—hematologic cancer	6.4e-06	7.23e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NUP214—hematologic cancer	6.39e-06	7.23e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPS14—hematologic cancer	6.39e-06	7.22e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GRB2—hematologic cancer	6.36e-06	7.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CD—hematologic cancer	6.35e-06	7.18e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFA—hematologic cancer	6.35e-06	7.18e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DKK1—hematologic cancer	6.34e-06	7.16e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.33e-06	7.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT5B—hematologic cancer	6.29e-06	7.11e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NUP98—hematologic cancer	6.29e-06	7.11e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCG2—hematologic cancer	6.26e-06	7.08e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTR—hematologic cancer	6.26e-06	7.08e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KITLG—hematologic cancer	6.26e-06	7.07e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH1—hematologic cancer	6.17e-06	6.97e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.17e-06	6.97e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CST3—hematologic cancer	6.15e-06	6.95e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ENO2—hematologic cancer	6.14e-06	6.94e-05	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—hematologic cancer	6.12e-06	6.92e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT5A—hematologic cancer	6.12e-06	6.91e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.12e-06	6.91e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ADCY7—hematologic cancer	6.1e-06	6.9e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCC3—hematologic cancer	6.1e-06	6.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TXN—hematologic cancer	6.1e-06	6.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTO1—hematologic cancer	6.1e-06	6.89e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CB—hematologic cancer	6.1e-06	6.89e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—hematologic cancer	6.06e-06	6.85e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NUP214—hematologic cancer	6.06e-06	6.85e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3R1—hematologic cancer	6e-06	6.78e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SPHK1—hematologic cancer	5.97e-06	6.75e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTT1—hematologic cancer	5.96e-06	6.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTR—hematologic cancer	5.94e-06	6.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—XIAP—hematologic cancer	5.94e-06	6.71e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.87e-06	6.63e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD86—hematologic cancer	5.86e-06	6.63e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—JAK2—hematologic cancer	5.83e-06	6.59e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SDC1—hematologic cancer	5.82e-06	6.58e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ENO2—hematologic cancer	5.82e-06	6.58e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMARCA4—hematologic cancer	5.79e-06	6.54e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HES1—hematologic cancer	5.78e-06	6.54e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NCOR1—hematologic cancer	5.75e-06	6.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—UGT1A1—hematologic cancer	5.73e-06	6.48e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CSF2—hematologic cancer	5.69e-06	6.43e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGF1—hematologic cancer	5.69e-06	6.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.62e-06	6.35e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FOXO1—hematologic cancer	5.6e-06	6.33e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—hematologic cancer	5.6e-06	6.33e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFRB—hematologic cancer	5.59e-06	6.32e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CRABP1—hematologic cancer	5.58e-06	6.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC22A1—hematologic cancer	5.58e-06	6.31e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.56e-06	6.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CB—hematologic cancer	5.54e-06	6.26e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SDC1—hematologic cancer	5.52e-06	6.24e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFRA—hematologic cancer	5.51e-06	6.22e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.49e-06	6.21e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAK1—hematologic cancer	5.49e-06	6.2e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PRKCG—hematologic cancer	5.49e-06	6.2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALOX5—hematologic cancer	5.44e-06	6.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.44e-06	6.14e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LCK—hematologic cancer	5.35e-06	6.04e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NUP98—hematologic cancer	5.27e-06	5.95e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.25e-06	5.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—H3F3A—hematologic cancer	5.24e-06	5.92e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2RA—hematologic cancer	5.13e-06	5.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADCY7—hematologic cancer	5.11e-06	5.78e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NCOA3—hematologic cancer	5.11e-06	5.78e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRKCZ—hematologic cancer	5.09e-06	5.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—hematologic cancer	5.09e-06	5.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NUP214—hematologic cancer	5.08e-06	5.74e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TERT—hematologic cancer	5.07e-06	5.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.02e-06	5.68e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CALR—hematologic cancer	5e-06	5.66e-05	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—hematologic cancer	5e-06	5.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCG2—hematologic cancer	4.97e-06	5.62e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTR—hematologic cancer	4.97e-06	5.62e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD44—hematologic cancer	4.95e-06	5.6e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NQO1—hematologic cancer	4.95e-06	5.6e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PDGFB—hematologic cancer	4.95e-06	5.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PARP1—hematologic cancer	4.92e-06	5.56e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ENO2—hematologic cancer	4.88e-06	5.51e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.85e-06	5.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBXW7—hematologic cancer	4.84e-06	5.47e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSC2—hematologic cancer	4.83e-06	5.46e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HDAC2—hematologic cancer	4.75e-06	5.37e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CXCR4—hematologic cancer	4.75e-06	5.37e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTT1—hematologic cancer	4.73e-06	5.35e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD44—hematologic cancer	4.69e-06	5.3e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYCS—hematologic cancer	4.68e-06	5.3e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.66e-06	5.26e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HSP90AA1—hematologic cancer	4.65e-06	5.26e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR3—hematologic cancer	4.65e-06	5.26e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CBL—hematologic cancer	4.63e-06	5.23e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SDC1—hematologic cancer	4.62e-06	5.23e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK14—hematologic cancer	4.6e-06	5.2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.59e-06	5.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—hematologic cancer	4.52e-06	5.11e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FN1—hematologic cancer	4.46e-06	5.04e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.42e-06	4.99e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HSP90AA1—hematologic cancer	4.41e-06	4.99e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BAD—hematologic cancer	4.41e-06	4.98e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFKBIA—hematologic cancer	4.41e-06	4.98e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NOTCH1—hematologic cancer	4.37e-06	4.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.36e-06	4.93e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CD80—hematologic cancer	4.28e-06	4.84e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CG—hematologic cancer	4.27e-06	4.83e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KIT—hematologic cancer	4.27e-06	4.83e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—hematologic cancer	4.27e-06	4.83e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT1—hematologic cancer	4.25e-06	4.81e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTPN11—hematologic cancer	4.19e-06	4.74e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.19e-06	4.74e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.17e-06	4.71e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTP1—hematologic cancer	4.13e-06	4.67e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MAPK3—hematologic cancer	4.09e-06	4.62e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CREB1—hematologic cancer	4.06e-06	4.59e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BRAF—hematologic cancer	4.01e-06	4.54e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4e-06	4.52e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GRB2—hematologic cancer	3.98e-06	4.5e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—hematologic cancer	3.98e-06	4.5e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFA—hematologic cancer	3.97e-06	4.49e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6R—hematologic cancer	3.96e-06	4.48e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CREBBP—hematologic cancer	3.96e-06	4.47e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NQO1—hematologic cancer	3.93e-06	4.44e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD44—hematologic cancer	3.93e-06	4.44e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KITLG—hematologic cancer	3.91e-06	4.42e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ABCB1—hematologic cancer	3.91e-06	4.42e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.85e-06	4.35e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT5A—hematologic cancer	3.83e-06	4.32e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GSTM1—hematologic cancer	3.79e-06	4.29e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NCOR1—hematologic cancer	3.79e-06	4.29e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—hematologic cancer	3.79e-06	4.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAP2K1—hematologic cancer	3.78e-06	4.27e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CD—hematologic cancer	3.75e-06	4.24e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYCS—hematologic cancer	3.72e-06	4.2e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—hematologic cancer	3.72e-06	4.2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HSP90AA1—hematologic cancer	3.7e-06	4.18e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—hematologic cancer	3.67e-06	4.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD86—hematologic cancer	3.67e-06	4.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HES1—hematologic cancer	3.62e-06	4.09e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NCOR1—hematologic cancer	3.6e-06	4.07e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGF2—hematologic cancer	3.59e-06	4.06e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGF1—hematologic cancer	3.56e-06	4.02e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3R1—hematologic cancer	3.54e-06	4.01e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FOXO1—hematologic cancer	3.51e-06	3.96e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFRB—hematologic cancer	3.5e-06	3.96e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JAK2—hematologic cancer	3.44e-06	3.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFRA—hematologic cancer	3.44e-06	3.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PRKCG—hematologic cancer	3.43e-06	3.88e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAK1—hematologic cancer	3.43e-06	3.88e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—hematologic cancer	3.38e-06	3.82e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MDM2—hematologic cancer	3.36e-06	3.8e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—hematologic cancer	3.35e-06	3.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.33e-06	3.76e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTP1—hematologic cancer	3.28e-06	3.71e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CB—hematologic cancer	3.27e-06	3.7e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MTOR—hematologic cancer	3.27e-06	3.7e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—hematologic cancer	3.18e-06	3.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.17e-06	3.59e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HLA-A—hematologic cancer	3.17e-06	3.58e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TERT—hematologic cancer	3.17e-06	3.58e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—hematologic cancer	3.12e-06	3.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ABCB1—hematologic cancer	3.1e-06	3.51e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PDGFB—hematologic cancer	3.09e-06	3.5e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—hematologic cancer	3.07e-06	3.47e-05	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—hematologic cancer	3.04e-06	3.43e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TSC2—hematologic cancer	3.02e-06	3.42e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NCOR1—hematologic cancer	3.01e-06	3.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GSTM1—hematologic cancer	3.01e-06	3.41e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CASP3—hematologic cancer	3.01e-06	3.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—hematologic cancer	3e-06	3.4e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—hematologic cancer	2.99e-06	3.38e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.96e-06	3.34e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCND1—hematologic cancer	2.93e-06	3.31e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—JUN—hematologic cancer	2.92e-06	3.3e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR3—hematologic cancer	2.91e-06	3.29e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1A—hematologic cancer	2.83e-06	3.2e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—hematologic cancer	2.83e-06	3.2e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CG—hematologic cancer	2.82e-06	3.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK8—hematologic cancer	2.77e-06	3.13e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—hematologic cancer	2.76e-06	3.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BAD—hematologic cancer	2.76e-06	3.12e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOTCH1—hematologic cancer	2.73e-06	3.09e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—hematologic cancer	2.7e-06	3.05e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD80—hematologic cancer	2.68e-06	3.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KIT—hematologic cancer	2.67e-06	3.02e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—hematologic cancer	2.66e-06	3.01e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTPN11—hematologic cancer	2.62e-06	2.97e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SRC—hematologic cancer	2.62e-06	2.96e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CREBBP—hematologic cancer	2.61e-06	2.95e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—hematologic cancer	2.55e-06	2.89e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CREB1—hematologic cancer	2.54e-06	2.87e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STAT3—hematologic cancer	2.53e-06	2.86e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—hematologic cancer	2.52e-06	2.85e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—BRAF—hematologic cancer	2.51e-06	2.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6R—hematologic cancer	2.48e-06	2.8e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CD—hematologic cancer	2.48e-06	2.8e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CREBBP—hematologic cancer	2.48e-06	2.8e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ALB—hematologic cancer	2.45e-06	2.76e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MAPK3—hematologic cancer	2.42e-06	2.73e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAP2K1—hematologic cancer	2.36e-06	2.67e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—hematologic cancer	2.35e-06	2.66e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CD—hematologic cancer	2.35e-06	2.65e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.35e-06	2.65e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—hematologic cancer	2.34e-06	2.65e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3R1—hematologic cancer	2.34e-06	2.64e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGF2—hematologic cancer	2.25e-06	2.54e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CG—hematologic cancer	2.24e-06	2.53e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3R1—hematologic cancer	2.22e-06	2.51e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—hematologic cancer	2.17e-06	2.45e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.16e-06	2.44e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—JAK2—hematologic cancer	2.15e-06	2.44e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MDM2—hematologic cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CREBBP—hematologic cancer	2.07e-06	2.34e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTOR—hematologic cancer	2.05e-06	2.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CB—hematologic cancer	2.05e-06	2.31e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—hematologic cancer	2.04e-06	2.31e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—hematologic cancer	1.99e-06	2.25e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CD—hematologic cancer	1.97e-06	2.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ALB—hematologic cancer	1.94e-06	2.19e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—hematologic cancer	1.93e-06	2.18e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—hematologic cancer	1.92e-06	2.17e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—hematologic cancer	1.87e-06	2.11e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3R1—hematologic cancer	1.86e-06	2.1e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—hematologic cancer	1.85e-06	2.09e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—hematologic cancer	1.78e-06	2.01e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1A—hematologic cancer	1.77e-06	2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—hematologic cancer	1.77e-06	2e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—hematologic cancer	1.77e-06	2e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CB—hematologic cancer	1.71e-06	1.94e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—hematologic cancer	1.69e-06	1.91e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SRC—hematologic cancer	1.64e-06	1.85e-05	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—hematologic cancer	1.63e-06	1.84e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—STAT3—hematologic cancer	1.58e-06	1.79e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—hematologic cancer	1.58e-06	1.78e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MAPK3—hematologic cancer	1.51e-06	1.71e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—hematologic cancer	1.48e-06	1.67e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—hematologic cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—hematologic cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—hematologic cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—hematologic cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.32e-06	1.49e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—hematologic cancer	1.25e-06	1.41e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—hematologic cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—hematologic cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—hematologic cancer	1.08e-06	1.22e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—hematologic cancer	1.02e-06	1.15e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—hematologic cancer	8.54e-07	9.65e-06	CbGpPWpGaD
